Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-26
2011-10-18
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S156000
Reexamination Certificate
active
08039485
ABSTRACT:
The present invention is directed to malate salts of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid, and its polymorphs. The present invention is also directed to pharmaceutical compositions comprising the described salts and polymorphs.
REFERENCES:
patent: 4017622 (1977-04-01), Minami et al.
patent: 4341784 (1982-07-01), Matsumoto et al.
patent: 4448962 (1984-05-01), Irikura et al.
patent: 4544658 (1985-10-01), Petersen et al.
patent: 4544747 (1985-10-01), Ishikawa et al.
patent: 4599334 (1986-07-01), Petersen et al.
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4771054 (1988-09-01), Domagala et al.
patent: 4780468 (1988-10-01), Bridges et al.
patent: 4822801 (1989-04-01), Domagala et al.
patent: 4844902 (1989-07-01), Grohe
patent: 4855292 (1989-08-01), Ueda et al.
patent: 4894458 (1990-01-01), Masuzawa et al.
patent: 4894548 (1990-01-01), Takahashi et al.
patent: 4920120 (1990-04-01), Domagala et al.
patent: 4988709 (1991-01-01), Ogata et al.
patent: 4990517 (1991-02-01), Petersen et al.
patent: 4994599 (1991-02-01), Chu
patent: 4997946 (1991-03-01), Edgar et al.
patent: 5043450 (1991-08-01), Masuzawa et al.
patent: 5051509 (1991-09-01), Nagano et al.
patent: 5072001 (1991-12-01), Hagen et al.
patent: 5098912 (1992-03-01), Hayakawa et al.
patent: 5116834 (1992-05-01), Domagala et al.
patent: 5157117 (1992-10-01), Takagi et al.
patent: 5229396 (1993-07-01), Brighty
patent: 5281612 (1994-01-01), Domagala et al.
patent: 5286723 (1994-02-01), Hayakawa et al.
patent: 5328908 (1994-07-01), Demuth, Jr. et al.
patent: 5348961 (1994-09-01), Iwata et al.
patent: 5364861 (1994-11-01), Hagen et al.
patent: 5387748 (1995-02-01), Demuth, Jr. et al.
patent: 5412098 (1995-05-01), Yasuhiro et al.
patent: 5457104 (1995-10-01), Bartel et al.
patent: 5464796 (1995-11-01), Petersen et al.
patent: 5480879 (1996-01-01), Petersen et al.
patent: 5519016 (1996-05-01), Kimura et al.
patent: 5547962 (1996-08-01), Ito et al.
patent: 5556979 (1996-09-01), Philipps et al.
patent: 5563155 (1996-10-01), Domagala et al.
patent: 5580872 (1996-12-01), Chu et al.
patent: 5599816 (1997-02-01), Chu et al.
patent: 5648567 (1997-07-01), Marhold et al.
patent: 5656623 (1997-08-01), White et al.
patent: 5726182 (1998-03-01), Chu et al.
patent: 5770597 (1998-06-01), Kim et al.
patent: 6235751 (2001-05-01), Park et al.
patent: 6329391 (2001-12-01), Ledoussal et al.
patent: 6387928 (2002-05-01), Ledoussal et al.
patent: 6645981 (2003-11-01), Ledoussal et al.
patent: 6803469 (2004-10-01), Randall
patent: 6849740 (2005-02-01), Ledoussal et al.
patent: 6900224 (2005-05-01), Ledoussal et al.
patent: 7019143 (2006-03-01), Ledoussal et al.
patent: 7456279 (2008-11-01), Reilly
patent: 7482454 (2009-01-01), Ledoussal et al.
patent: 7528264 (2009-05-01), Hayes et al.
patent: 2002/0049192 (2002-04-01), Ledoussal et al.
patent: 2002/0173501 (2002-11-01), Ledoussal et al.
patent: 2003/0007862 (2003-01-01), Ohtachi et al.
patent: 2005/0101589 (2005-05-01), Ledoussal et al.
patent: 2006/0052359 (2006-03-01), Grant et al.
patent: 2006/0100436 (2006-05-01), Ledoussal et al.
patent: 2073993 (1993-01-01), None
patent: 2152828 (1994-07-01), None
patent: 2212226 (1995-10-01), None
patent: 2217164 (1996-10-01), None
patent: 2238765 (1997-05-01), None
patent: 2228536 (1998-08-01), None
patent: 2212007 (2004-09-01), None
patent: 318-85 (1985-08-01), None
patent: 1086515 (1994-05-01), None
patent: 9201901 (1993-01-01), None
patent: 9302001 (1994-04-01), None
patent: 9400100 (1995-03-01), None
patent: 0106489 (1984-04-01), None
patent: 0195841 (1986-01-01), None
patent: 0195316 (1986-09-01), None
patent: 207497 (1987-01-01), None
patent: 230295 (1987-07-01), None
patent: 235762 (1987-09-01), None
patent: 237955 (1987-09-01), None
patent: 0308019 (1989-03-01), None
patent: 0342675 (1989-11-01), None
patent: 0366189 (1990-05-01), None
patent: 0413455 (1991-02-01), None
patent: 443498 (1991-08-01), None
patent: 0464823 (1992-01-01), None
patent: 550016 (1993-07-01), None
patent: 0572259 (1993-12-01), None
patent: 0 641 793 (1995-03-01), None
patent: 0775702 (1997-05-01), None
patent: 0947513 (1999-10-01), None
patent: 219910 (1993-03-01), None
patent: 1279532 (1997-01-01), None
patent: 51-086476 (1976-07-01), None
patent: 61-205258 (1986-09-01), None
patent: 61-225181 (1986-10-01), None
patent: 01-056673 (1987-08-01), None
patent: 62-255482 (1987-11-01), None
patent: 64-016767 (1989-01-01), None
patent: 03-115277 (1991-05-01), None
patent: 97244733 (1991-08-01), None
patent: 5-58895 (1993-03-01), None
patent: 05-11-2554 (1993-05-01), None
patent: 05-345777 (1993-12-01), None
patent: 07-48367 (1995-02-01), None
patent: 8133977 (1996-05-01), None
patent: 09-002953 (1997-01-01), None
patent: 09-052893 (1997-02-01), None
patent: 10-287669 (1997-04-01), None
patent: 09-136886 (1997-05-01), None
patent: 97178847 (1997-06-01), None
patent: 97240318 (1997-08-01), None
patent: 11-12278 (1999-01-01), None
patent: 11-60578 (1999-03-01), None
patent: 3745433 (2006-02-01), None
patent: 91/16894 (1991-11-01), None
patent: 95/10519 (1995-04-01), None
patent: 96/39407 (1996-12-01), None
patent: WO 97/19072 (1997-05-01), None
patent: WO 97/29102 (1997-08-01), None
patent: 98/52939 (1998-11-01), None
patent: 98/54169 (1998-12-01), None
patent: 99/07696 (1999-02-01), None
patent: WO 99/14214 (1999-03-01), None
patent: 00/21952 (2000-04-01), None
patent: 00/78748 (2000-12-01), None
patent: 01/53273 (2001-07-01), None
patent: 02/48138 (2002-06-01), None
patent: 2004/014893 (2004-02-01), None
patent: WO 2005/033108 (2005-04-01), None
Lauderdale et al. “Comparative in vitro . . . ” Antimicrob. agents and chemother. v.54(3) p. 1338-1342 (2010).
Radem-furi et al. “Process for preparation . . . ” CA 147:469244 (2007).
Yokota et al. Chiral separation . . . ) J. Chem. Eng. Japan v. 37, p. 1284-1285 (2004).
Zhang et al. “Racemic species . . . ” J. Pharm. Sci. v.92, p. 1356-1366 (2003).
Fasel et al. “Amplification of chirality . . . ” Nature v. 439, p. 449-452 (2006).
Braga et al. “Making crystals from . . . ” Roy. soc. Chem.Chem. commun. p. 3635-3645 (2005).
U.S. Appl. No. 10/085,786, filed Feb. 28, 2002, Ledoussal, et al.
U.S. Appl. No. 11/301,685, filed Dec. 13, 2005, Ledoussal, et al.
U.S. Appl. No. 11/728,342, filed Mar. 26, 2007, Reilly, Michael.
U.S. Appl. No. 11/728,341, filed Mar. 26, 2007, Hayes, Michael Patrick et al.
Bastin, Richard J., et al., “Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities,” Organic Process Research & Development, 2000, vol. 4, pp. 427-435.
Albrecht, “Development of Antibacterial Agents of the Nalidixic Acid Type,” Prog. In Drug Research, 21 (1977) pp. 9-104.
Berge, M., et al., “Pharmaceutical Salts,” Journal of Pharmaceutical Sciences, Jan. 1977, vol. 66, No. 1, pp. 1-19.
Bouzard, et al., “Fluoronaphthyridines and Quinolones as Antibacterial Agents, 1. Synthesis and Structure-Activity Relationships of New 1-Substituted Derivatives”, J.Med. Chem., 32 (1989), pp. 537-542.
Cecchetti, V., et al., “Potent 6-Desfluoro-8-methylquinolones as New Lead Compounds in Antibacterial Chemotherapy,” J. Med. Chem., vol. 39, pp. 4952-4957 (1996).
Cecchetti, et al., “Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-methylquinolones”, J. Med. Chem., 39 (1996) pp. 4952-4957.
Chemical Abstracts 96: 47559 1981 Otsuka.
Chemical Abstracts 120: 298485,1993, Ito.
Chemical Abstracts 126: 157539, 1994, Abstract by Bartel.
Chemical Abstracts 130: 223178, 1999, Tojima.
Chemical Abstracts 130: 124998, 1999, Yamamoto.
Chemical Abstracts 129: 343410, 1998, Takemura.
Chemical Abstracts 129: 153244, 1998, Sawa.
Cornett et al., “Chap. 14. Quinolone Antibacterial Agents”, Annual Reports in Medicinal Chemistry, 1985, pp. 145-154.
Domagala et al., “7-Substituted 5-Amino-1 cyclopropyl-6,8-difluoro-1,4-dihyro-4oxo3-quinolinecarboxylic Acids: Synthesis and Biological Ac
Dicks Michael Lloyd
Godlewski Jane Ellen
Redman-Furey Nancy Lee
Chang Celia
Fitzpatrick ,Cella, Harper & Scinto
Warner Chilcott Company LLC
LandOfFree
Malate salts, and polymorphs of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Malate salts, and polymorphs of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Malate salts, and polymorphs of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4267780